Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 1,250 shares at $15.45 ($19K) on 2014-05-16, disclosed to the SEC on 2014-05-20.
Seasonal sale ($19k) by SVP Pharmaceutical Development & Mfg — this insider has traded AMRI in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |